Enteroviral infections, both endemic and epidemic forms, are known as worldwide viral infections in patients affecting all age groups. This group of viruses causes a wide range of clinical syndromes such as respiratory and gastrointestinal infections, poliomyelitis, mono-neuritis, and poly-neuritis (
1). This virus is known as a common cause of central nervous system (CNS) infection such as encephalitis and aseptic meningitis (
2-
4). Enteroviral meningitis is usually benign but sometimes it may be accompanied by death or severe sequels such as epilepsy, encephalitis, and neonatal sepsis (
5). Life-threatening infections may appear in certain patients on which therapeutic drugs have limited effects. Additionally, antibody-deficient patients may develop chronic CNS infections, often with lethal outcomes (
6). In a similar study in Iran, enterovirus serotype of EV71 was the major cause of the disease, especially in very young children (
7). However, pleconaril, pocapavir, and vapendavir are three antiviral agents, which are being clinically evaluated for enteroviral infections (
8,
9).
On the other hand, the clinical features and cerebrospinal fluid (CSF) analysis of the patients with enteroviral CNS infections may be similar to those of bacterial or herpetic infections, resulting in wrong diagnosis, prolonged hospital stay, and unnecessary empiric antibiotic prescription until the definitive diagnosis is made (
8,
10,
11). A specific virological diagnosis of enteroviral meningitis depends on the isolation of virus from the CSF in tissue culture (
3,
12). But this test is expensive and not available every time and everywhere. However, CSF PCR is rapid and more sensitive than isolation of virus for the diagnosis (
13). PCR is the most promising alternations to viral culture for the diagnosis of Enteroviral meningitis (
12).